Methotrexate - Only for Children Pharmaceuticals
Alternative Names: PhillaLatest Information Update: 21 Jan 2022
At a glance
- Originator Only for Children Pharmaceuticals
- Class Abortifacients; Anti-inflammatories; Antiasthmatics; Antifibrotics; Antineoplastics; Antipsoriatics; Antirheumatics; Benzamides; Disease-modifying antirheumatics; Eye disorder therapies; Glutamates; Heart failure therapies; Pterins; Small molecules
- Mechanism of Action Tetrahydrofolate dehydrogenase inhibitors; Thymidylate synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Juvenile rheumatoid arthritis; Precursor cell lymphoblastic leukaemia-lymphoma
Most Recent Events
- 28 Jun 2020 No recent reports of development identified for research development in Juvenile-rheumatoid-arthritis in France (Injection)
- 28 Jun 2020 No recent reports of development identified for research development in Precursor-cell-lymphoblastic-leukaemia-lymphoma in France (PO, Liquid)
- 11 May 2016 Chemical structure information added